Efavirenz intoxication due to slow hepatic metabolism

Autor: M. Krause, Gabriela Bleiber, Barbara Hasse, Huldrych F. Günthard
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Adult
Cyclopropanes
Microbiology (medical)
Psychosis
Efavirenz
CYP2B6
Anti-HIV Agents
Human immunodeficiency virus (HIV)
HIV Infections
Pharmacology
medicine.disease_cause
Psychoses
Substance-Induced

chemistry.chemical_compound
immune system diseases
Oxazines
parasitic diseases
medicine
Humans
Genetic Predisposition to Disease
heterocyclic compounds
Allele
Alleles
Dose-Response Relationship
Drug

business.industry
Homozygote
Anti-HIV Agents/adverse effects
Anti-HIV Agents/blood
Anti-HIV Agents/metabolism
Aryl Hydrocarbon Hydroxylases/genetics
HIV Infections/drug therapy
Liver/enzymology
Oxazines/adverse effects
Oxazines/blood
Oxazines/metabolism
Oxidoreductases
N-Demethylating/genetics

Psychoses
Substance-Induced/diagnosis

virus diseases
Oxidoreductases
N-Demethylating

biochemical phenomena
metabolism
and nutrition

Hiv seropositivity
medicine.disease
Benzoxazines
Cytochrome P-450 CYP2B6
Infectious Diseases
Liver metabolism
Liver
chemistry
Alkynes
Immunology
Female
Aryl Hydrocarbon Hydroxylases
business
Drug metabolism
Zdroj: Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 40, no. 3, pp. e22-e23
Popis: We describe a human immunodeficiency virus-positive woman who presented with severe psychosis while she was receiving therapy with efavirenz. Her plasma efavirenz level was excessively high. Genetic investigation showed that she was homozygous for the CYP2B6 G516T allele, resulting in slow hepatic metabolism. After the dosage of efavirenz was lowered, all neuropsychiatric symptoms subsided.
Databáze: OpenAIRE